By Krishna N. Das

NEW DELHI (Reuters) -Some Indian pharmaceutical firms failed to follow rules that every batch of medicinal ingredients is tested, the country’s drug regulator said on Wednesday, after deaths in the past month of 17 children linked to toxic cough syrups.

An advisory by the drugs controller general of India, Rajeev Raghuvanshi, said the regulator carried out checks at some factories and found serious lapses. In the advisory dated October 7 and posted on a government website on Wednesday, Raghuvanshi did not name any companies or the number of companies that were found to have flouted norms, but said the inspections had been carried out at firms whose drugs had earlier been found to be of “not of standard quality”.

By law, Indian drugmakers have to test each batch of raw

See Full Page